NO20050961L - R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning - Google Patents

R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning

Info

Publication number
NO20050961L
NO20050961L NO20050961A NO20050961A NO20050961L NO 20050961 L NO20050961 L NO 20050961L NO 20050961 A NO20050961 A NO 20050961A NO 20050961 A NO20050961 A NO 20050961A NO 20050961 L NO20050961 L NO 20050961L
Authority
NO
Norway
Prior art keywords
amino
alkyl
hydroxypropanoic acid
gem
diphenyl
Prior art date
Application number
NO20050961A
Other languages
English (en)
Norwegian (no)
Inventor
Camille Georges Wermuth
Kathleen Clarence-Smith
Jean-Marie Georges Contreras
Laurence Nathalie Deyon
Original Assignee
Prestwick Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prestwick Pharmaceuticals Inc filed Critical Prestwick Pharmaceuticals Inc
Publication of NO20050961L publication Critical patent/NO20050961L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20050961A 2002-08-14 2005-02-23 R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning NO20050961L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0210306A FR2843590B1 (fr) 2002-08-14 2002-08-14 Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
PCT/FR2003/002447 WO2004016580A2 (fr) 2002-08-14 2003-08-01 Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique

Publications (1)

Publication Number Publication Date
NO20050961L true NO20050961L (no) 2005-04-28

Family

ID=30775996

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050961A NO20050961L (no) 2002-08-14 2005-02-23 R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning

Country Status (19)

Country Link
US (1) US7488755B2 (pl)
EP (1) EP1529030A2 (pl)
JP (1) JP2005535715A (pl)
KR (2) KR100890674B1 (pl)
CN (1) CN1675169A (pl)
AU (1) AU2003274213B2 (pl)
BR (1) BR0313740A (pl)
CA (1) CA2497347A1 (pl)
CR (1) CR7736A (pl)
EA (1) EA010417B1 (pl)
FR (1) FR2843590B1 (pl)
GE (1) GEP20074194B (pl)
IL (1) IL166778A0 (pl)
MX (1) MXPA05001761A (pl)
NO (1) NO20050961L (pl)
NZ (1) NZ538633A (pl)
PL (1) PL375413A1 (pl)
UA (1) UA80559C2 (pl)
WO (1) WO2004016580A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013072936A2 (en) * 2011-11-10 2013-05-23 Ramamohan Rao Davuluri A novel process for the preparation of (r)-n-benzyl-2 acetamido-3-methoxypropionamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬
US5332758A (en) * 1990-07-13 1994-07-26 Kanebo, Ltd. Collagen metabolism ameliorant and its use
ES2036926B1 (es) * 1991-08-08 1994-01-16 Uriach & Cia Sa J "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
GB9425730D0 (en) 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
PT871440E (pt) * 1995-12-07 2006-07-31 Daniel C Javitt Tratamento de sintomas negativos e cognitivos de esquizofrenia com antagonistas da captacao de glicina
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
EP1073432B1 (en) * 1998-04-14 2007-08-15 The General Hospital Corporation Use of d-serine or d-alanine for treating schizophrenia
GB2410947B (en) 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
CR7736A (es) 2008-10-10
EA010417B1 (ru) 2008-08-29
IL166778A0 (en) 2006-01-15
AU2003274213B2 (en) 2008-03-13
MXPA05001761A (es) 2005-04-25
KR20070067250A (ko) 2007-06-27
KR20050055697A (ko) 2005-06-13
EA200500333A1 (ru) 2005-08-25
KR100890674B1 (ko) 2009-03-26
WO2004016580A3 (fr) 2004-04-08
PL375413A1 (pl) 2005-11-28
US7488755B2 (en) 2009-02-10
NZ538633A (en) 2007-10-26
CN1675169A (zh) 2005-09-28
EP1529030A2 (fr) 2005-05-11
JP2005535715A (ja) 2005-11-24
UA80559C2 (en) 2007-10-10
AU2003274213A1 (en) 2004-03-03
FR2843590A1 (fr) 2004-02-20
FR2843590B1 (fr) 2007-10-05
US20050261372A1 (en) 2005-11-24
CA2497347A1 (en) 2004-02-26
GEP20074194B (en) 2007-09-10
KR100756138B1 (ko) 2007-09-05
BR0313740A (pt) 2005-07-19
WO2004016580A2 (fr) 2004-02-26

Similar Documents

Publication Publication Date Title
BR0312729A (pt) Novos derivados de indol-3-enxofre
NO20052914L (no) Terapeutiske forbindelser
BR0015624A (pt) Uso de um composto, composto, composição farmacêutica, e, método de tratamento ou profilaxia de doenças ou condições humanas
BRPI0413695A (pt) derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas
NO20065878L (no) Terapeutiske forbindelser
NO20065904L (no) Terapeutiske forbindelser
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
NO20076319L (no) Farmasoytiske sammensetninger av et neuroaktivt steroid og anvendelse derav
MY138352A (en) Benzothiazole derivatives
JO2282B1 (en) Oxazole derivatives
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
NO20082445L (no) Neuropeptid-2 reseptor-agonister
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
EA200500583A1 (ru) Ингибиторы белка-регулятора трансмембранной проводимости при муковисцидозе и их применение
ES2098947T3 (es) Derivados de beta,beta-dimetil-4-piperidinoetanamina como inhibidores de la biosintesis del colesterol.
BR0308796A (pt) Derivados de benzofurano
NO20024324D0 (no) Legemidler for diagnose av vevsreproduktiv aktivitet eller behandling av proliferative sykdommer
CA2302568A1 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
BRPI0413013A (pt) composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BRPI0416882A (pt) composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
PL360492A1 (pl) Zastosowanie kwasu pamowego lub jednej z jego pochodnych lub jednego z jego analogów do wytwarzanialeku do leczenia chorób charakteryzujących się odkładaniem amyloidowych agregatów
HUP0104308A2 (hu) Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
CA2143252A1 (fr) Derives de benzodioxane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NO20050961L (no) R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application